BRNS
NASDAQ:BRNS
Barinthus Biotherapeutics plc
- Stock
locale
United Kingdom
market
STOCKSindustry
Biotechnologywebsite
www.barinthusbio.comipo date
Apr 30, 2021
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. It is advancing a pipeline of product candidates across a range of therapeutic areas, including VTP-300, an immunotherapeutic candidate designed as a potenti...Show More